Cargando…

The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017

BACKGROUND: Due to limited therapeutic options and their association with high mortality and morbidity, carbapenem-non-susceptible Acinetobacter spp. (CNA) are of significant public health importance. This study aimed to describe current epidemiological trends of CNA proportions in Europe and to ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayobami, Olaniyi, Willrich, Niklas, Suwono, Beneditta, Eckmanns, Tim, Markwart, Robby
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304165/ https://www.ncbi.nlm.nih.gov/pubmed/32560670 http://dx.doi.org/10.1186/s13756-020-00750-5

Ejemplares similares

The incidence and prevalence of hospital-acquired (carbapenem-resistant) Acinetobacter baumannii in Europe, Eastern Mediterranean and Africa: a systematic review and meta-analysis
por: Ayobami, Olaniyi, et al.
Publicado: (2019)

The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): an analysis of data from the national Antimicrobial Resistance Surveillance system
por: Said, Dunja, et al.
Publicado: (2021)

The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
por: Ayobami, Olaniyi, et al.
Publicado: (2020)

Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe
por: Markwart, Robby, et al.
Publicado: (2021)

Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis
por: Ayobami, Olaniyi, et al.
Publicado: (2022)

Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020
por: Brinkwirth, Simon, et al.
Publicado: (2021)

Authors reply: comments on the published meta-analysis of antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries
por: Ayobami, Olaniyi, et al.
Publicado: (2022)

A Joint Regional Analysis of Resistance Combinations in Escherichia coli in Humans and Different Food-Producing Animal Populations in Germany Between 2014 and 2017
por: Suwono, Beneditta, et al.
Publicado: (2022)

SARS-CoV-2 outbreaks in hospitals and long-term care facilities in Germany: a national observational study
por: Suwono, Beneditta, et al.
Publicado: (2022)

Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: a systematic review and meta-analysis, 1 January 2010 to 31 December 2021
por: Rödenbeck, Maria, et al.
Publicado: (2023)

The rise in vancomycin-resistant Enterococcus faecium in Germany: data from the German Antimicrobial Resistance Surveillance (ARS)
por: Markwart, Robby, et al.
Publicado: (2019)

Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019
por: von Laer, Anja, et al.
Publicado: (2022)

Antimicrobial Resistance and the Spectrum of Pathogens in Dental and Oral-Maxillofacial Infections in Hospitals and Dental Practices in Germany
por: Meinen, Annika, et al.
Publicado: (2021)

Cluster analysis of resistance combinations in Escherichia coli from different human and animal populations in Germany 2014-2017
por: Suwono, Beneditta, et al.
Publicado: (2021)

Germany’s Burden of Disease of Bloodstream Infections Due to Vancomycin-Resistant Enterococcus faecium between 2015–2020
por: Brinkwirth, Simon, et al.
Publicado: (2022)

548. Carbapenem-Resistant Acinetobacter baumannii Antibiotic Susceptibility Testing and Antibiogram Formation, Connecticut 2017–2019
por: Paranandi, Anu, et al.
Publicado: (2019)

The Containment Scouts: First Insights into an Initiative to Increase the Public Health Workforce for Contact Tracing during the COVID-19 Pandemic in Germany
por: Said, Dunja, et al.
Publicado: (2021)

Molecular Epidemiology of Carbapenem Non-Susceptible Acinetobacter baumannii in France
por: Jeannot, Katy, et al.
Publicado: (2014)

Seasonal Occurrence and Carbapenem Susceptibility of Bovine Acinetobacter baumannii in Germany
por: Klotz, Peter, et al.
Publicado: (2019)

Comparison of MICs in Escherichia coli isolates from human health surveillance with MICs obtained for the same isolates by broth microdilution
por: Suwono, Beneditta, et al.
Publicado: (2021)

545. Incidence of Carbapenem Non-Susceptible Acinetobacter spp. and Carbapenem-Resistant Pseudomonas aeruginosa Clinical Cultures among Patients in US Acute Care Hospitals, 2012–2017
por: Kazakova, Sophia, et al.
Publicado: (2019)

Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant Acinetobacter baumannii in Europe, 2019
por: Lötsch, Felix, et al.
Publicado: (2020)

Minocycline Susceptibility and tetB Gene in Carbapenem-Resistant Acinetobacter baumannii in Taiwan
por: Yang, Jia-Ling, et al.
Publicado: (2022)

Zidebactam restores sulbactam susceptibility against carbapenem-resistant Acinetobacter baumannii isolates
por: Cedano, Jose, et al.
Publicado: (2022)

Epidemiology of healthcare-associated SARS-CoV-2 outbreaks in Germany between March 2020 and May 2022
por: Suwono, B., et al.
Publicado: (2023)

1490. Serious Infections Caused by Carbapenem Susceptible and Carbapenem Resistant Acinetobacter baumannii-calcoaceticus Complex - A Retrospective Review
por: Rana, Khurram, et al.
Publicado: (2020)

Correlation between Carbapenem Consumption and Carbapenems Susceptibility Profiles of Acinetobacter baumannii and Pseudomonas aeruginosa in an Academic Medical Center in Thailand
por: Paiboonvong, Taniya, et al.
Publicado: (2022)

Effects of Group 1 versus Group 2 Carbapenems on the Susceptibility of Acinetobacter baumannii to Carbapenems: A Before and After Intervention Study of Carbapenem-Use Stewardship
por: Yoon, Young Kyung, et al.
Publicado: (2014)

Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013–2017
por: Gupta, Vikas, et al.
Publicado: (2019)

Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility
por: Abbey, Taylor, et al.
Publicado: (2022)

Increase of invasive meningococcal serogroup W disease in Europe, 2013 to 2017
por: Krone, Manuel, et al.
Publicado: (2019)

Faecal Carriage of Carbapenem-Resistant Acinetobacter baumannii: Comparison to Clinical Isolates from the Same Period (2017–2019)
por: Balázs, Bence, et al.
Publicado: (2022)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Epidemiology and burden of sepsis acquired in hospitals and intensive care units: a systematic review and meta-analysis
por: Markwart, Robby, et al.
Publicado: (2020)

In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy
por: Mezzatesta, Maria Lina, et al.
Publicado: (2008)

Challenges in diagnosing community-acquired carbapenem-susceptible Acinetobacter baumannii enterogenic sepsis: A case report
por: Ye, Gongjie, et al.
Publicado: (2019)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

Clonal Spread of Carbapenem Non-susceptible Acinetobacter baumannii in an Intensive Care Unit in a Teaching Hospital in China
por: Zhong, Qiao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pc0gtplupgoulsjvatm5m5d4pq